ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant.

November 14, 2008

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

Help Wanted: Varmus Irked by Having to Fill Jobs With Salaries NCI Can’t Afford to Pay

July 6, 2012

Cancer Groups Urge Support For Comprehensive Cancer Care Legislation.

June 29, 2007

MSKCC Wins Zoning Request For New Labs.

February 8, 2002

No Cancer Letter for Two Weeks

August 13, 1993